This inventor holds 1 USPTO granted patent. Top assignee: Mbd Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mi Sun Kim - Innovator in Metabolic Disease Treatment
Introduction
Mi Sun Kim is a prominent inventor based in Gwacheon-si, South Korea. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target metabolic diseases. Her innovative work has led to the creation of a novel compound that shows promise in treating various health conditions.
Latest Patents
Mi Sun Kim holds 1 patent for her invention titled "Heterocyclic CYP4A inhibitor compounds and compositions thereof." This patent describes a novel quinoline or quinazoline compound that exhibits excellent inhibitory activity against cytochrome P450 4A (CYP4A). The compound has potential applications in preventing, relieving, or treating metabolic diseases, showcasing her commitment to advancing medical science.
Career Highlights
Mi Sun Kim is currently employed at MBD Co., Ltd., where she continues to innovate and develop new therapeutic solutions. Her work at the company reflects her dedication to improving health outcomes through scientific research and development.
Collaborations
Throughout her career, Mi Sun Kim has collaborated with notable colleagues, including Bo Sung Ku and Ho Sang Moon. These partnerships have enhanced her research efforts and contributed to the success of her projects.
Conclusion
Mi Sun Kim is a trailblazer in the field of medicinal chemistry, with her innovative patent addressing critical health issues related to metabolic diseases. Her contributions to science and collaboration with esteemed colleagues highlight her impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile